Verrica Pharmaceuticals (NASDAQ:VRCA) Receives “Hold” Rating from Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a research report released on Wednesday,Benzinga reports. Verrica Pharmaceuticals Trading Down 9.1 % Shares of VRCA stock opened at $0.54 on Wednesday. The firm has a market capitalization of $24.50 million, a PE ratio of -0.29 and […]
